EXHIBIT 10.1
ASSET PURCHASE
AGREEMENT
By and Among
BLACKHAWK BIOFUELS,
LLC,
RENEWABLE ENERGY GROUP,
INC.,
BIOFUELS COMPANY OF AMERICA,
LLC,
BIODIESEL INVESTMENT GROUP,
LLC
and
BUNGE NORTH AMERICA,
INC.
Dated as of March 14,
2008
TABLE OF CONTENTS
|
|
|
Page
|
|
|
|
|
|
ARTICLE I
|
PURCHASE AND SALE OF
ASSETS
|
1
|
|
Section 1.1
|
Purchase and
Sale
|
1
|
|
Section 1.2
|
Consideration; Purchase
Price Allocation
|
1
|
|
Section 1.3
|
Closing
|
3
|
|
Section 1.4
|
Procedure at
Closing
|
4
|
|
|
|
|
|
ARTICLE II
|
REPRESENTATIONS AS TO
THE COMPANY
|
4
|
|
Section 2.1
|
Organization and Good
Standing
|
4
|
|
Section 2.2
|
Noncontravention;
Authority; Enforceability
|
4
|
|
Section 2.3
|
Subsidiaries
|
5
|
|
Section 2.4
|
Title to and Condition
of the Assets
|
5
|
|
Section 2.5
|
Real
Property
|
5
|
|
Section 2.6
|
Material Adverse
Changes
|
7
|
|
Section 2.7
|
Environmental
Compliance
|
8
|
|
Section 2.8
|
Contracts and
Commitments
|
9
|
|
Section 2.9
|
No
Litigation
|
10
|
|
Section 2.10
|
Tax Matters
|
10
|
|
Section 2.11
|
Compliance with
Laws
|
10
|
|
Section 2.12
|
Permits
|
11
|
|
Section 2.13
|
Insurance
|
11
|
|
Section 2.14
|
Employee
Matters
|
11
|
|
Section 2.15
|
Benefit
Plans
|
12
|
|
Section 2.16
|
Intellectual
Property
|
12
|
|
Section 2.17
|
Brokers
|
12
|
|
Section 2.18
|
Accuracy of
Statements
|
12
|
|
Section 2.19
|
Purchase Entirely for
Own Account
|
12
|
|
Section 2.20
|
Disclosure of
Information; Due Diligence
|
12
|
|
Section 2.21
|
Investment Experience;
Accredited Status
|
13
|
|
Section 2.22
|
Restricted
Securities
|
13
|
|
Section 2.23
|
Investment
Company
|
13
|
|
|
|
|
|
ARTICLE III
|
REPRESENTATIONS OF REG
AND THE PURCHASER
|
13
|
|
Section 3.1
|
Organization and
Existence
|
13
|
|
Section 3.2
|
Authority
|
14
|
|
Section 3.3
|
Noncontravention
|
14
|
|
Section 3.4
|
Capitalization; REG
Common Stock
|
14
|
|
Section 3.5
|
Financial
Information
|
15
|
|
Section 3.6
|
Undisclosed
Liabilities
|
15
|
|
Section 3.7
|
Material Adverse
Changes
|
15
|
|
Section 3.8
|
Brokers
|
15
|
i
|
ARTICLE IV
|
NO ASSUMPTION OF
LIABILITIES
|
16
|
|
|
|
|
|
ARTICLE V
|
COVENANTS
|
16
|
|
Section 5.1
|
Access to
Information
|
16
|
|
Section 5.2
|
Pre-Closing
Activities
|
17
|
|
Section 5.3
|
Efforts to
Consummate
|
18
|
|
Section 5.4
|
Exclusive
Dealing
|
18
|
|
Section 5.5
|
Supplementation and
Amendment of Schedules
|
18
|
|
Section 5.6
|
Confidentiality
|
19
|
|
Section 5.7
|
Publicity
|
19
|
|
Section 5.8
|
Preliminary Testing;
Performance Testing
|
19
|
|
Section 5.9
|
Bunge Oil Supply
Agreement; Services Agreement
|
19
|
|
Section 5.10
|
Limitations on
Disposition and Legend
|
19
|
|
|
|
|
|
ARTICLE VI
|
CONDITIONS TO
CLOSING
|
21
|
|
Section 6.1
|
Conditions to
Obligations of the Purchaser and REG
|
21
|
|
Section 6.2
|
Conditions to
Obligations of the Sellers and the Company
|
22
|
|
Section 6.3
|
Documents to be
Delivered at the Closing
|
24
|
|
|
|
|
|
ARTICLE VII
|
INDEMNIFICATION
|
25
|
|
Section 7.1
|
Indemnification by the
Sellers
|
25
|
|
Section 7.2
|
Indemnification by the
Purchaser
|
26
|
|
Section 7.3
|
Notice and Defense of
Third Party Claims
|
26
|
|
Section 7.4
|
Limitations of
Liability
|
28
|
|
Section 7.5
|
Survival
|
29
|
|
Section 7.6
|
Waiver of Certain
Damages
|
29
|
|
Section 7.7
|
Express
Negligence
|
29
|
|
|
|
|
|
ARTICLE VIII
|
TERMINATION
|
30
|
|
Section 8.1
|
Termination
|
30
|
|
Section 8.2
|
Effect of Termination;
Liquidated Damages
|
30
|
|
|
|
|
|
ARTICLE IX
|
MISCELLANEOUS
|
31
|
|
Section 9.1
|
Survival
|
31
|
|
Section 9.2
|
Amendment and
Modification; Waiver
|
31
|
|
Section 9.3
|
Notices
|
31
|
|
Section 9.4
|
Further
Assurances
|
33
|
|
Section 9.5
|
Assignment
|
33
|
|
Section 9.6
|
Governing
Law
|
34
|
|
Section 9.7
|
Severability
|
34
|
|
Section 9.8
|
Counterparts
|
34
|
|
Section 9.9
|
Facsimile
Signatures
|
34
|
|
Section 9.10
|
No Third-Party
Beneficiaries
|
34
|
|
Section 9.11
|
Interpretation
|
34
|
|
Section 9.12
|
Entire
Agreement
|
34
|
ii
|
Section 9.13
|
Expenses
|
34
|
|
Section 9.14
|
Jury Waiver
|
34
|
EXHIBITS AND
SCHEDULES
|
Exhibit A
|
|
Definitions
|
|
Exhibit B
|
|
Escrow
Agreement
|
|
Exhibit C
|
|
Oil Feedstock Supply
Agreement
|
|
Exhibit D
|
|
Services
Agreement
|
|
Exhibit E
|
|
Bill of Sale
|
|
Exhibit F
|
|
Assignment and
Assumption Agreement
|
|
Exhibit G
|
|
Confidentiality
Agreement
|
|
Exhibit H
|
|
Stockholder
Agreement
|
|
Exhibit I
|
|
Registration Rights
Agreement
|
|
Exhibit J
|
|
Preliminary Testing
Description
|
|
|
|
|
|
Schedule 2.2
|
|
Noncontravention
|
|
Schedule 2.4
|
|
Title to
Assets
|
|
Schedule
2.5(a)
|
|
Description of Real
Property
|
|
Schedule
2.5(c)(vi)
|
|
Right of First Offer,
etc.
|
|
Schedule
2.5(c)(viii)
|
|
Utilities
Exceptions
|
|
Schedule 2.7
|
|
Environmental
Compliance
|
|
Schedule
2.8(b)
|
|
Breach of Assumed
Contract
|
|
Schedule
2.8(c)
|
|
Notice of Claims Under
Assumed Contract
|
|
Schedule
2.8(d)
|
|
Consents and
Notices
|
|
Schedule
2.11
|
|
Compliance with
Laws
|
|
Schedule
2.12
|
|
Permits
|
|
Schedule
2.13
|
|
Insurance
|
|
Schedule
2.14
|
|
Employee
Matters
|
|
Schedule
2.15
|
|
Benefit
Plans
|
|
Schedule
2.16
|
|
Intellectual
Property
|
|
Schedule
2.17
|
|
Brokers
|
|
Schedule 3.5
|
|
REG Financial
Information
|
|
Schedule 3.6
|
|
Undisclosed
Liabilities
|
|
Schedule 4
|
|
Assumed
Contracts
|
|
Schedule 5.2
|
|
Pre-Closing
Activities
|
iii
ASSET PURCHASE
AGREEMENT
This Asset Purchase Agreement (the “
Agreement ”) is made as of this 14 th day
of March, 2008 (the “ Effective Date ”), by and
among Blackhawk Biofuels, LLC, a Delaware limited liability company
(“ Purchaser ”), Renewable Energy
Group, Inc., a Delaware corporation (“ REG
”), Biofuels Company of America, LLC, an Illinois limited
liability company (the “ Company ”), Biodiesel
Investment Group, LLC, a Delaware limited liability company
(“ BIG ”), and Bunge North America, Inc., a
New York corporation (“ Bunge ”, and together
with BIG, the “ Members ” and each, a
“Member” and Bunge, BIG and the Company together are
referred to herein as “Sellers” and each a
“Seller”). Certain capitalized terms not defined
in the text of this Agreement are defined in Exhibit A
attached hereto.
WHEREAS, the Company is constructing a
biodiesel production facility located in Danville, Illinois (the
“Facility”);
WHEREAS, BIG and Bunge own, beneficially and of
record, one hundred percent (100%) of the outstanding membership
interests of the Company (the “ Company Membership
Interests ”);
WHEREAS, the Purchaser desires to purchase and
assume from the Company, and the Members desire that the Company
shall sell, transfer and assign to the Purchaser, all of the Assets
of the Company, upon the terms and subject to the conditions set
forth in this Agreement;
WHEREAS, a portion of the consideration to be
delivered consists of shares of common stock of REG; and
WHEREAS, each of the parties hereto is making
certain representations, warranties, covenants and indemnities
herein to induce the others to enter into this
Agreement.
NOW, THEREFORE, in consideration of the
respective representations, warranties, covenants and indemnities
contained herein and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the
Company, the Members, REG and the Purchaser hereby agree as
follows:
ARTICLE I
PURCHASE AND SALE OF ASSETS
Section 1.1
Purchase and Sale. Subject to the terms and
conditions of this Agreement, at the Closing (as defined in
Section 1.3 hereof), the Company agrees to sell,
transfer, assign, convey and deliver to the Purchaser, and the
Purchaser agrees to purchase and assume from the Company, all of
the right, title and interest in and to the Assets (other than
Excluded Assets), free and clear of all Encumbrances except for
Permitted Liens.
Section 1.2
Consideration ; Purchase Price
Allocation. In consideration of
the purchase and sale described
above, Purchaser, and as to
the common stock of REG in Sections 1.2(b) and
1.2(c) only REG, shall pay to the Company, in the
manner and subject to the conditions set forth below, the following
(the “ Purchase Price ”):
(a)
Cash. On the Closing
Date, in addition to the Escrowed Cash, (i) Purchaser shall
pay to the Company Five Million U.S. Dollars (U.S. $5,000,000) (the
“ Cash Purchase Price ”) by wire transfer of
immediately available funds to such account as designated by the
Company, and Bunge and BIG shall agree prior to Closing as between
themselves the amounts to be received by Bunge and BIG upon
distribution by the Company to the Members of the Cash Purchase
Price (less appropriate reserves established by the Company, if
any), and (ii) Company shall pay the IFA Payment to the IFA by
wire transfer of immediately available funds to such account as
designated by IFA;
(b)
REG Common Stock. On
the Closing Date, in addition to the Escrowed Stock, REG shall
issue and cause to be delivered by Purchaser to the Company, and
Purchaser shall deliver to the Company One Million Eight Hundred
Eighty-two Thousand Nine Hundred Twenty-seven (1,882,927) shares of
the common stock of REG (the “ REG Common Stock
”), as adjusted for any post-Effective Date dividend, stock
split, recapitalization or reorganization by REG, by delivery of
REG Common Stock certificates to the Company. Bunge and BIG
shall agree prior to Closing as between themselves the number of
shares to be received by Bunge and BIG upon distribution by the
Company to the Members of the REG Common Stock (less appropriate
reserves established by the Company, if any);
(c)
Escrow. On the
Closing Date, Purchaser shall deposit Two Hundred Fifty Thousand
Dollars ($250,000) (the “ Escrowed Cash ”) and
REG shall deposit Ninety-Seven Thousand Five Hundred Sixty-One
(97,561) shares of the common stock of REG, as adjusted for any
post-Effective Date dividend, stock split, recapitalization or
reorganization by REG by delivery of stock certificates in the name
of the Company (the “ Escrowed Stock ” and
together with the Escrowed Cash, the “ Escrow Amount
”) into an escrow account (the “ Escrow Fund
”), to be maintained by an escrow agent reasonably acceptable
to the parties (the “ Escrow Agent ”) in
accordance with the terms of an Escrow Agreement in the form
attached hereto as Exhibit B (the “ Escrow
Agreement ”). The Escrow Fund shall be used for the
purpose specified in Article VII herein. The Escrow Fund
(less any amounts for indemnifiable Losses to the extent set forth
in Article VII and the Escrow Agreement) shall be disbursed to
the Company in accordance with the terms of the Escrow Agreement on
the one year anniversary of the Closing Date. Purchaser and
the Company shall bear an equal portion of the fees and expenses of
the Escrow Agent, with the portion borne by the Company to be
deducted from the Escrow Fund. Bunge and BIG shall agree
prior to Closing as between themselves the percentages of Escrowed
Cash and Escrowed Stock to be received by Bunge and BIG upon
distribution by the Company to the Members of the Escrow Fund;
provided, that a Member’s percentage of the Escrow Fund shall
be reduced by the amount of any indemnifiable Loss made pursuant to
the terms of the Escrow Agreement and this Agreement applicable to
such Member.
(d)
Balance Differential
Payment. In the event the outstanding principal balance,
together with any accrued, but unpaid interest, owed by the Company
to Fifth Third Bank under the Construction Loan Agreement (the
“ Bank Balance ”) plus the
2
Assumed Liabilities
less the DCEO Grant Credit less the Reimbursements (collectively,
the “ Closing Indebtedness ”) is less than
$24,650,000 as of the Closing Date, Purchaser shall pay to the
Company on the Closing Date the difference between $24,650,000 and
the Closing Indebtedness in cash by wire transfer of immediately
available funds (the “Balance Differential Payment
”)
. Bunge and BIG
hereby agree as between themselves that Bunge shall receive 22.2%
of the Balance Differential Payment and BIG shall receive 77.8% of
the Balance Differential Payment. To determine the Balance
Differential Payment, if any, the Company shall deliver to
Purchaser (i) a statement of account from Fifth Third Bank of
the Bank Balance as of the Closing Date, and (ii) a statement
of the Assumed Liabilities as of the Closing Date, together with
supporting documentation. The amount of the Bank Balance plus
Assumed Liabilities less the DCEO Grant Credit less the
Reimbursements shall not exceed $24,650,000 and the Company shall
pay any liabilities in excess of such amount. The parties
agree to the following additional adjustments conditional and
effective upon Closing: (a) the Company shall pay for
its insurance and interest expense; (b) the Company shall pay
for the cost of security through the successful completion of the
Preliminary Testing and thereafter Purchaser shall reimburse the
Company for security expenses incurred consistent with past
practice; (c) Purchaser shall reimburse the Company at cost
for raw material inputs for production at the Facility which are
reasonably and necessarily incurred by the Company prior to
Closing; (d) Purchaser shall reimburse the Company for utility
expenses commencing March 15, 2008 through the Closing Date;
and (e) Purchaser shall pay for or reimburse the Company for
the expense of Ambitech (Bill Cloyd) incurred prior to Closing as
it relates to management of the Facility upgrades only, but not
otherwise. Any such adjustments shall be settled at
Closing. Any such reimbursements to the extent allowed by
Fifth Third Bank as an advance against the Construction Loan
Agreement by the Company shall be referenced herein as the “
Reimbursements ”.
(e)
Purchase Price
Allocation. The Purchase Price shall be allocated among the
Assets as the Company, the Members, Purchaser and REG shall
mutually agree, in writing, at the Closing. After the
Closing, the Company, the Members and Purchaser shall make
consistent use of such mutually agreed allocation for all tax
purposes and in all filings, declarations and reports with the IRS
in respect thereof. Purchaser shall prepare and deliver IRS
Form 8594 to the Company in accordance with such mutual
agreement within forty-five (45) days after the Closing Date for
filing with the IRS.
(f)
Value of the Common Stock
of REG. The parties hereto agree that the common stock of REG
making up the REG Common Stock delivered at Closing and the
Escrowed Stock shall be valued at $10.25 per share for all purposes
under this Agreement, including without limitation, any purchase
price allocations and any agreement or right of the Members or the
Company to satisfy their indemnification obligations under
Article VII by the surrender of the common stock of
REG.
Section 1.3
Closing. Subject to satisfaction or
waiver of the conditions to closing set forth in Sections
6.1 and 6.2 , the closing of the purchase
provided for in Section 1.1 of this Agreement (the
“ Closing ”) shall take place at the offices of
Nyemaster, Goode, West, Hansell &
3
O’Brien, P.C., counsel
to REG, in Des Moines, Iowa at 10:00 a.m. local time on the
next Business Day after the conditions to closing set forth in
Sections 6.1 and 6.2 have been satisfied or waived,
or at such other place and time as may be mutually agreeable to the
Company, the Members, REG and the Purchaser (such date and time
referred to herein as the “ Closing Date
”). The parties anticipate the Closing Date to occur on
or before April 11, 2008 (the “ Target Closing
Date ”).
Section 1.4
Procedure at
Closing. At the Closing, the parties agree that the
following shall occur:
(a)
Each of the conditions
precedent (as applicable) in Section 6.1 shall have
been satisfied, or such condition(s) shall have been expressly
waived in writing by the Purchaser and REG. The Company and/or the
Members shall deliver to Purchaser and REG all of the documents in
Section 6.3 .
(b)
Each of the conditions
precedent (as applicable) in Section 6.2 shall have
been satisfied, or such condition(s) shall have been expressly
waived in writing by the Company and the Members. The
Purchaser and REG shall deliver to the Members and the Company all
of the documents required in Section 6.3 .
(c) All of the documents and
instruments delivered at the Closing shall be in form and
substance, and shall be executed and delivered in a manner,
reasonably satisfactory to the parties’ respective
counsel.
ARTICLE II
REPRESENTATIONS AS TO THE COMPANY
Each Seller, severally as to itself only and
not jointly as to or with any of the others, respectively,
represents and warrants to the Purchaser as follows:
Section 2.1
Organization and Good Standing.
The Company is a limited
liability company duly organized and validly existing under the
laws of the State of Illinois and has all requisite power and
authority to carry on its business as is now being conducted and as
is presently anticipated being conducted, and with respect to a
Member, such Member is duly organized, validly existing and in good
standing under the laws of the state of its organization. The
Company is not qualified as a foreign limited liability company in
any other jurisdiction. The Company has at all times been
operated in material compliance with applicable Legal Requirements
and the Company’s Organizational Documents.
Section 2.2
Noncontravention; Authority;
Enforceability. Except as disclosed on
Schedule 2.2 of the Company Disclosure Schedule, neither the
execution and delivery by such Seller of this Agreement and the
Transaction Documents, as applicable, nor the consummation of the
transactions contemplated hereby or thereby, nor compliance with
any of the provisions hereof or thereof, will (a) violate any
provision of its Organizational Documents or any resolutions
adopted by its members, stockholders, board of managers or board of
directors, (b) result in a violation of any license, permit,
order, writ, injunction, decree, judgment, or ruling of any court
or Governmental Authority, or any law, rule, or regulation
applicable to such Seller, (c) conflict with, result in a
breach of, or constitute (or, with due notice or lapse of time or
both,
4
would constitute) a default
under, or give rise to any right of termination, acceleration or
cancellation under, any indenture, agreement, contract, license,
arrangement, understanding, evidence of indebtedness, note, lease
or other instrument which constitutes an Asset or to which such
Seller or any of the Assets is bound, (d) result in the
creation or imposition of any lien (other than Permitted Liens),
charge, restriction, claim or Encumbrance of any nature whatsoever
upon the Company or the Assets or (e) require any consent or
approval of, or notice to, or filing or registration with, any
Person, except for those consents, approvals, notices, filings, or
registrations that have been obtained, given, or made, as the case
may be, and that are unconditional and in full force and
effect. Such Seller has the requisite corporate or limited
liability company power and authority to execute and deliver this
Agreement and the Transaction Documents to which such Seller is a
party, to perform its obligations hereunder and thereunder, and to
consummate the transactions contemplated by this Agreement and the
Transaction Documents. The
Company has authorized and approved by all requisite action of the
Board of Managers and members of the Company, this Agreement, the
Transaction Documents and the transactions contemplated hereby and
thereby. The execution, delivery and performance by such
Seller of this Agreement and the Transaction Documents, as
applicable, and the consummation by such Seller of the transactions
contemplated hereby and thereby have been duly and validly
authorized by all necessary corporate or limited liability company
action. This Agreement and the Transaction Documents to which
such Seller, as applicable, is a party have been duly executed and
delivered by such Seller and are the valid and binding obligations
of such Seller enforceable against such Seller in accordance with
the terms hereof and thereof, except as enforceability may be
limited by bankruptcy, insolvency, moratorium, fraudulent
conveyance and other similar laws affecting creditors’ rights
generally and by general principles of equity.
Section 2.3
Subsidiaries. The
Company does not own, directly or indirectly, any interest in any
other Entity.
Section 2.4
Title to and Condition of the
Assets.
(a)
The Company has, and at
the Closing shall transfer to Purchaser, good and marketable title
to the Assets, including without limitation the Assets described on
Schedule 2.4 , free and clear of all Encumbrances other than
Permitted Liens. With respect to those assets which are
leased, except as set forth on Schedule 2.4 , the Company is
in compliance with each such lease and holds a valid leasehold
interest, free and clear of all Encumbrances other than Permitted
Liens. As of the Closing Date, the tangible Assets shall be
in sound operating condition and repair, normal wear and tear
excepted.
(b)
As of the Closing Date,
the Assets set forth on Schedule 2.4 constitute all of the
assets which have been delivered to the Facility under the Fagen
Agreement and the De Smet Agreement.
Section 2.5
Real Property.
(a)
The Company does not own
any real property. Schedule 2.5(a) of the
Company Disclosure Schedule contains a legal description of each
parcel of real property that the Company leases, subleases,
licenses, occupies, or uses in connection with the operation of the
business of the Company as presently conducted or proposed to
be
5
conducted upon
completion of the Facility (the “ Real Property
”). The parcels of Real Property which are leased or
subleased by the Company and which leases or subleases will be
assigned to Purchaser at the Closing, as identified on Schedule
2.5(a) , are referred to herein as “ Leased Real
Property ”, and the parcels of Real Property which are
licensed or sublicensed by the Company and which will be assigned
to Purchaser, as identified on Schedule 2.5(a) , are
referred to herein as “ Licensed Real Property
”. Except as set forth on Schedule 2.5(a)
of the Company Disclosure Schedule, no right to use or occupy
any portion of the Leased Real Property has been granted to any
Person other than Company nor are there any parties in possession
of any portion of the Leased Real Property, whether as tenants,
subtenants, trespassers or otherwise, except the
Company.
(b)
The Company has a valid
leasehold interest in the Leased Real Property, free and clear of
all Encumbrances, other than Permitted Liens. To the
Knowledge of the Company, the Company has a valid license or
sublicense to occupy and use the Licensed Real Property. The
Company has paid, discharged or reserved for, all lawful claims
that, if unpaid, could become an Encumbrance against the Leased
Real Property or any portion thereof.
(c)
With respect to each
parcel of Leased Real Property and the buildings, structures,
improvements and fixtures thereon:
(i)
No condemnation or eminent
domain taking of the Leased Real Property, or any portion thereof,
has occurred. There is no pending, and to the Knowledge of
the Company, threatened or contemplated, appropriation,
condemnation, eminent domain or like proceeding affecting the
Leased Real Property or any part thereof or of any sale or other
disposition of the Leased Real Property or any part thereof in lieu
of condemnation.
(ii)
Except for assessments
occurring on a regular basis in accordance with applicable Legal
Requirements, there is no pending or, to the Knowledge of the
Company, contemplated reassessment of any parcel included in the
Leased Real Property that is reasonably expected to increase the
real estate tax assessment for such properties.
(iii)
There is no pending, or to
the Knowledge of the Company, contemplated proceeding to rezone any
parcel of the Leased Real Property. To the Knowledge of the
Company, the uses for which each parcel of the Leased Real Property
are zoned do not restrict, or in any manner impair, the current use
of the Leased Real Property or the proposed use by the
Purchaser. To the Knowledge of the Company, the Company has
not received notice of any violation of any applicable zoning law,
regulation or other Legal Requirement, related to or affecting the
Leased Real Property.
(iv)
To the Knowledge of the
Company, all buildings, structures and other improvements on the
Leased Real Property, including but not limited to driveways,
garages, landscaped areas and sewer systems, and all means of
access to the Leased Real Property, are located completely within
the boundary lines of
6
the
Leased Real Property and do not encroach upon or under the property
of any other Person or entity. No buildings, structures or
improvements constructed on the property of any other Person
encroach upon or under the Leased Real Property.
(v)
To the Knowledge of the
Company, the use of the Leased Real Property, or any portion
thereof, does not violate or conflict with (i) any covenants,
conditions or restrictions applicable thereto or (ii) the
terms and provisions of any contractual obligations relating
thereto.
(vi)
Except as set forth on
Schedule 2.5(c)(vi) of the Company Disclosure
Schedule, none of the Leased Real Property is subject to any right
of first offer, right of first refusal, option or other agreement
for the sale or lease thereof.
(vii)
The Company has good and
valid rights of ingress and egress to and from all of the Leased
Real Property (including between separate parcels included within
the Leased Real Property) from and to pipelines (including, but not
limited to, pipelines to access the rail loading area) and the
public street systems for all usual street, road and utility
purposes and other purposes necessary or incidental to the
operation of the business of the Company conducted or proposed to
be conducted upon completion of the Facility.
(viii) Except as set forth on Schedule
2.5(c)(viii) of the Company Disclosure Schedule, to the
Knowledge of the Company, all utilities required for or useful in
the operation of the business of the Company either enter the
Leased Real Property through adjoining streets and roads, or if
they pass through adjoining private land, they do so in accordance
with valid public easements. All necessary utilities
(including without limitation, water, sewer, electricity and
telephone facilities) are available to the Leased Real Property and
there exists, to the Knowledge of the Company, no proposed
limitation in or reduction of the quality or quantity of utility
services to be furnished to the Leased Real Property.
Permanent adequate sewage and water systems and connections are
available to the Leased Real Property as currently
operated.
(ix)
No Proceeding is pending
or, to the Knowledge of the Company, is threatened, to revoke,
suspend, modify or limit any of the permits required under
applicable Legal Requirements with respect to its leasehold
interest in and use and occupancy of, the Leased Real
Property. Except as set forth on Schedule 2.8(d)
of the Company Disclosure Schedule, no Permit will be subject
to revocation, suspension, modification or limitation as a result
of this Agreement or the consummation of the transactions
contemplated hereby.
Section 2.6
Material Adverse Changes. Since December 31,
2007, there has been no, and no event has had or reasonably could
be anticipated to have a, Material Adverse Effect with respect to
the Company or the Assets. Without limiting the generality of
the foregoing, since December 31, 2007, none of the following
has occurred:
7
(a)
any destruction, damage to
or loss of any Asset (whether or not covered by insurance), which
individually exceeds $20,000 in value or in the aggregate exceeds
$50,000 in value;
(b)
any act or omission to do
any act which would cause the breach of any material term or
material obligation applicable to the Company under any Assumed
Contract;
(c)
any execution, creation,
amendment or termination of any material contract, agreement or
license or any other transaction relating to the Assets, except in
the ordinary course of business of the Company or except as
otherwise agreed to in writing by Purchaser and REG;
(d)
any notice of any
litigation or claim relating to the Company or the
Assets;
(e)
any waiver or release of
any material right or claim with respect to the Company or any of
the Assets except for change orders provided to the Purchaser and
REG by the Company as described on Schedule 4 of the Company
Disclosure Schedule;
(f)
any mortgage, pledge or
other encumbrance on any Asset other than Permitted Liens;
or
(g)
any agreement by Sellers
to do any of the foregoing.
Section 2.7
Environmental Compliance
(a)
None of the Company or the
Assets are subject to any past, existing, pending, or threatened
action, suit, investigation, claim, demand, directive, inquiry, or
proceeding by any Governmental Authority or any other Person
alleging liability or responsibility in connection with Hazardous
Materials, or under any Legal Requirement pertaining to health, the
environment, or the regulation of Hazardous Materials (as defined
below) (collectively, “ Environmental Laws ”),
nor is any of them otherwise subject to any remedial or other
obligation or liability (including without limitation STRICT
LIABILITY ) under Environmental Laws. There is no
condition, fact, situation or event that currently constitutes or
with the passage of time would constitute a violation by the
Company of, or result in liability (including without limitation
STRICT LIABILITY ) of the Company or the Assets under,
Environmental Laws. The Company and the Assets have complied
and are in compliance with all Environmental Laws.
(b)
Each of the statements set
forth in clauses (i) and (ii) below is true and correct
with respect to the Company and the Assets:
(i)
all Governmental
Authorizations, if any, required to be obtained or filed pursuant
to Environmental Laws in connection with the operations,
activities, uses, vehicles, equipment or facilities at, on, in or
under, such Assets or otherwise of the Company, including, without
limitation, for the past or present treatment, storage, handling,
use, discharge or “ Release ” (which includes
any
8
spilling, leaking, pumping, pouring, emitting,
emptying, discharging, injecting, escaping, leaching, dumping, or
disposing) of any pollutant, contaminant, solid waste, hydrocarbon,
toxic or hazardous substance or waste, any flammable, corrosive,
explosive, or radioactive materials or any other material, waste,
or substance regulated under the Environmental Laws (a “
Hazardous Material ”) into the environment or indoor
air, or any filling, dredging, discharging into, or other uses or
activities on or affecting water of the United States, including
wetlands (as defined under the Federal Clean Water Act and 33
C.F.R. §328.3) (“ Environmental Permits ”),
have been duly obtained and are in good standing; and the Company
and the Assets have all pollution control equipment necessary to
comply with all Environmental Permits and Environmental Laws, and
have timely filed applications for renewal of all Environmental
Permits and has no reason for belief that such Environmental
Permits or renewals thereof will be subject to any new or changed
conditions; and
(ii)
there have been no
(A) Releases or threatened Releases of Hazardous Materials,
and no Hazardous Materials are present in quantities or
concentrations exceeding any applicable standard under
Environmental Laws, at, in, under, on or affecting any of the
Assets, nor (B) Releases or threatened Releases on or to any
other properties of any Hazardous Materials generated or produced
on or at, or transported from, the Assets or by or on behalf of the
Company that would violate or create liability (including, without
limitation, STRICT LIABILITY ) under Environmental
Laws.
(c)
The Company has provided
accurate and complete copies of all Environmental Permits, and all
environmental reviews, investigations and/or assessments in the
possession of the Company or such Member or otherwise conducted by
or on behalf of the Company or such Member, with respect to the
Company and/or the Assets. Each such Environmental Permit,
review, investigation or assessment is described on Schedule
2.7 of the Company Disclosure Schedule.
Section 2.8
Contracts and Commitments.
(a)
The Assumed Contracts are
valid and in full force and effect and constitute the legal, valid,
and binding obligations of the Company, and to the Knowledge of the
Company, each other party thereto, and true and correct copies of
which, including, but not limited to, any amendment, modification
or waiver thereof, have been provided to the Purchaser or
REG. Sellers do not have any knowledge that any Assumed
Contract is not a valid and binding agreement of the other parties
thereto.
(b)
The Company (i) has
performed all the obligations required to be performed by it to
date in all material respects (or has received a valid, enforceable
and irrevocable written waiver with respect to its non-performance)
and (ii) has received no notice of default and is not in
default in any material respect (or, with due notice or lapse of
time or both, would be in default) under any Assumed
Contract. Except as set forth on Schedule 2.8(b)
of the Company Disclosure Schedule, the Company has no
present expectation or intention of terminating or not materially
performing any of its obligations
9
under any Assumed Contract, and the Company has
no Knowledge of any breach or anticipated breach by the other party
to any Assumed Contract.
(c)
Except as set forth on
Schedule 2.8(c) of the Company Disclosure Schedule,
(i) no previous or current party to any Assumed Contract has
given written notice to the Company or such Member of, or made any
claim with respect to, a desire or intention to exercise any
optional termination, cancellation, non-renewal or acceleration
right thereunder, and the Company has no Knowledge of any notice
of, or claim with respect to, any such desire or intention and
(ii) the Company has not given written notice to any previous
or current party to any Assumed Contract of, nor made any claim
with respect to, a desire or intention to exercise any optional
termination, cancellation, non-renewal or acceleration right
thereunder.
(d)
No consent or approval of
or notice to any third party pursuant to any Assumed Contract is
required to be obtained or made by or with respect to the Company
in connection with the execution, delivery and performance of any
transaction contemplated by this Agreement or any other Transaction
Documents except as set forth in Schedule 2.8(d) of
the Company Disclosure Schedule (“ Required Consents
”).
Section 2.9
No
Litigation. There are no
Proceedings pending or, to the Knowledge of the Company, threatened
against the Company or involving any of the Assets. Neither
the Company nor any of the Assets are subject to any judgment,
order, writ, injunction, or decree of any Governmental
Authority. There are no Proceedings pending, or to the
Knowledge of the Company, threatened seeking to restrain, prohibit,
or obtain damages in connection with this Agreement or the
transactions contemplated hereby.
Section 2.10
Tax
Matters. The Company has filed or
caused to be filed on or before their due date all Tax Returns that
they are required to file and have paid all Taxes due and payable
on such Tax Returns or on any assessments made against the Company
or any of the Assets and all other Taxes imposed on the Company or
any of the Assets (except for Tax Returns for which valid
extensions have been obtained and are in force). All such Tax
Returns were and will be accurate, correct and complete in all
material respects and were prepared in the manner required by
applicable laws. For all periods (or portions thereof) ending
on or before the Closing Date for which Tax Returns are not yet
due, the Company has either paid or adequately reserved for Taxes
accrued for such periods. There are no Tax liens upon any of
the Assets, other than liens for Taxes not yet due and payable and
there is no threatened audit, dispute or claim that might result in
a lien on any of the Assets. There are no audits, disputes,
claims or threatened assessments concerning any Tax liability of
the Company or that are related to the Assets. The Company is
a pass-through entity treated as a partnership for federal, state
and local income tax purposes. As of the date of this
Agreement, the Company has not commenced operations and has filed
no income Tax Returns. The Company has withheld and paid all
Taxes required to have been withheld and paid in connection with
amounts paid or owing to any employee, independent contractor,
creditor, or other third party. The Company has made all
deposits required with respect to Taxes due and payable by the
Company.
Section 2.11
Compliance with Laws. Except as set forth on
Schedule 2.11 of the Company Disclosure Schedule, the
Company is, and at all times since its formation has been,
in
10
material compliance with all
Legal Requirements applicable to the Company or to the ownership or
operation of the Assets or the operation of its business, and has
no basis to expect, nor has it received any Order, notice, or other
communication from any Governmental Authority of any alleged,
actual, or potential material violation and/or failure to
materially comply with any Legal Requirement applicable to the
Company or to the ownership or operation of the
Assets.
Section 2.12
Permits. Except as set forth on
Schedule 2.12 of the Company Disclosure Schedule, the
Company has obtained all material Governmental Authorizations
required to permit them to (a) develop and construct a
biodiesel operating facility, (b) own, operate, use, and maintain
the Assets in the manner in which they are now operated and
maintained, or (c) to conduct its business as now being
conducted, including, without limitation, all Environmental
Permits. Schedule 2.12 sets forth a true, correct and
complete list of all such Governmental Authorizations, copies of
which have previously been delivered by the Company to Purchaser
and REG. Except as set forth on Schedule 2.12 of the
Company Disclosure Schedule, all required filings with respect to
such Governmental Authorizations have been made timely.
Except as set forth on Schedule 2.12 of the Company
Disclosure Schedule, all such Governmental Authorizations are in
full force and effect and there are no Proceedings pending or, to
the Knowledge of the Company, threatened that seek the revocation,
cancellation, suspension or other materially adverse modification
thereof. No consent, license, permit, authorization or order
of, or registration, declaration or filing with or of any
Governmental Authority or other issuer of any permit is required to
be obtained or made by or with respect to the Company in connection
with the execution, delivery and performance of any transactions
contemplated by this Agreement or any of the Transaction Documents
except as set forth on Schedule 2.12 of the Company
Disclosure Schedule.
Section 2.13
Insurance. Schedule 2.13
of the Company Disclosure
Schedule sets forth all insurance policies owned or held by the
Company as in effect on the Effective Date and which shall be
maintained through the Closing Date. All policies of fire,
liability, casualty and other forms of insurance owned or held by
the Company: (a) are sufficient for compliance with all
requirements of law and of all agreements of the Company,
(b) are valid, outstanding and enforceable policies, and
(c) will not in any way be affected by, or terminate or lapse
by reason of, the transactions contemplated by this
Agreement.
Section 2.14
Employee Matters. The only individual retained
by the Company to perform services is Mark A. Burke, who serves as
its President and is an independent contractor and not an employee
of the Company. Mr. Burke is subject to at will
termination at any time, with or without cause, and for any reason
or no reason, without the payment of any severance payment or other
amount except accrued salary at the rate specified on Schedule
2.14 of the Company Disclosure Schedule and except that
Mr. Burke is entitled to receive a payment in connection with
the consummation of the transactions contemplated by this
Agreement, as described on Schedule 2.14 of the Company
Disclosure Schedule, which payment shall be paid directly by the
Members or the Company. The Company is not a party to any
collective bargaining agreements or union contracts. The
Company has not received notice of any claim that it has not
complied with any laws relating to the employment of labor,
including any provisions thereof relating to wages, hours,
collective bargaining, the payment of social security and similar
taxes, equal employment opportunity, employment discrimination, or
employment safety, or that the Company is liable for any arrears of
wages or any taxes or penalties for failure
11
to comply with any of the
foregoing. The Company is in compliance with all applicable
legal requirements respecting employment, employment practices,
labor, terms and conditions of employment and wages and
hours.
Section 2.15
Benefit Plans. Except as set forth on
Schedule 2.15 of the Company Disclosure Schedule, the
Company is not a party to and has no liabilities in respect of, or
under, any employee benefit plan (as such term is defined in
Section 3(3) of ERISA), any employee pension benefit plan
(as such term is defined in Section 3(2) of ERISA,
including without limitation any multiemployer pension plan within
the meaning of Section 3(37) of ERISA), any deferred
compensation arrangement, any bonus, incentive compensation,
employment agreement, severance agreement, or any other similar
type of plan, program or arrangement providing for employee
benefits (“ Employee Benefit Plans
”).
Section 2.16
Intellectual Property.
Schedule 2.16
of the Company Disclosure
Schedule sets forth all Intellectual Property Assets that the
Company owns, uses or licenses in its business. The Company
owns or licenses all Intellectual Property Assets necessary to
operate its business as presently conducted or intended to be
conducted upon completion of the Facility. To the Knowledge
of the Company, there is no intellectual property of any third
party that infringes any of the Intellectual Property Assets owned
by the Company. None of the Intellectual Property Assets
owned or used by the Company infringe upon or, to the Knowledge of
the Company, is alleged to infringe upon, any intellectual property
right of any other person or entity.
Section 2.17
Brokers. Except as set forth on
Schedule 2.17 of the Company Disclosure Schedule, neither
the Company nor such Member has paid or become obligated to pay any
fee or commission to any broker, finder, intermediary, advisor,
consultant, or appraiser for or on account of the transactions
contemplated by this Agreement and the Transaction
Documents.
Section 2.18
Accuracy of Statements.
Neither this Agreement nor
any schedule, exhibit, statement, list, document, certificate or
other information furnished or to be furnished by or on behalf of
the Company or such Member to the Purchaser or REG in connection
with this Agreement or any of the transactions contemplated by this
Agreement contains any untrue statement of a material fact or omits
to state a material fact necessary to make the statements contained
herein or therein, in light of the circumstances in which they are
made, not misleading.
Section 2.19
Purchase Entirely for Own Account.
The REG Common Stock to be
received by the Company and such Member is and will be acquired for
investment for its own account and not with a view to the
distribution of any part thereof, and the Company has no present
intention of selling, granting any participation in, or otherwise
distributing the same; provided, however, that the Company reserves
the right to distribute its shares of REG Common Stock to its
Members subject to Section 5.10 hereof and the terms and
conditions of the Stockholder Agreement.
Section 2.20
Disclosure of Information; Due
Diligence. The Company and such
Member has had the opportunity to ask questions of and receive
answers from REG regarding REG and the terms and conditions of the
offering of the REG Common Stock and to obtain additional
information necessary to verify the accuracy of the information
supplied or to which it had access. Such Seller acknowledges
and agrees that the Purchaser does not assume any
12
responsibility or liability
with respect to the REG Common Stock or the information provided
with respect to REG, the REG Common Stock or the investment therein
by the Company represented by the consideration received by the
Company hereunder. Such Seller further acknowledges and
agrees that the Purchaser is not acting as an underwriter with
respect to the REG Common Stock and assumes no underwriters’
liability in connection therewith.
Section 2.21
Investment Experience; Accredited
Status. The Company and such Member
acknowledge that an investment in REG is a speculative risk.
The Company and such Member are able to fend for themselves in the
transactions contemplated by this Agreement, can bear the economic
risk of its investment (including possible complete loss of such
investment) for an indefinite period of time and has such knowledge
and experience in financial or business matters that it is capable
of evaluating the merits and risks of the investment in REG.
The Company and such Member understand that the shares of REG
Common Stock to be purchased hereunder have not been registered
under the Securities Act, or under the securities laws of any
jurisdiction, by reason of reliance upon certain exemptions, and
that the reliance on such exemptions is predicated, in part, upon
the accuracy of the Member’s representations and warranties
in this Article III. The Company and such Member are
familiar with Regulation D promulgated under the Securities Act and
represent that they are each an “accredited investor”
as defined in Rule 501(a) of such Regulation
D.
Section 2.22
Restricted Securities. The Company and such Member
understand that the shares of REG Common Stock to be received by
the Company and such Member hereunder are characterized as
“restricted securities” under the federal securities
laws inasmuch as they are being acquired from REG through the
Purchaser in a transaction not involving a public offering and that
under such laws and applicable regulations such securities may be
resold without registration under the Securities Act only in
certain limited circumstances and in accordance with the terms and
conditions set forth in the legend contained on the certificates of
the REG Common Stock. The Company and such Member represent
that they are familiar with SEC Rule 144, as presently in
effect, and understand the resale limitations imposed thereby and
by the Securities Act.
Section 2.23
Investment Company.
The Company and such Member
(or any Person directly or
indirectly controlling the Company and
such Member or on whose behalf the
Company is acting) are not, and by virtue of the consummation of
the transactions contemplated herein will not be, an
“investment company” within the meaning of the
Investment Company Act of 1940, as amended, or an exemption or
exclusion from the registration provisions under the Investment
Company Act of 1940, as amended, is available to the Company, such
Member or any such Person.
ARTICLE III
REPRESENTATIONS OF REG AND THE PURCHASER
Each of the Purchaser and REG, severally as to
itself only and not jointly as to or with the other, respectively,
represents and warrants to the Sellers as follows:
Section 3.1
Organization and Existence. The Purchaser and REG are
each duly organized, validly existing and in good standing under
the laws of their jurisdiction of
13
incorporation or
organization, respectively, and have all requisite power and
authority to carry on their respective businesses as now being
conducted.
Section 3.2
Authority. All corporate,
limited liability company or other appropriate action on the part
of the Purchaser and REG necessary for the authorization, execution
and delivery of this Agreement and the Transaction Documents
contemplated hereby to which the Purchaser or REG, respectively, is
a party, and the performance of the obligations of the Purchaser
and REG hereunder and thereunder, have been taken. The
Purchaser and REG have each duly and validly executed and delivered
this Agreement and each of the Transaction Documents contemplated
hereby to which the Purchaser or REG, respectively, is a
party. This Agreement and each of the Transaction Documents
contemplated hereby to which the Purchaser or REG is a party
constitutes valid and binding obligations of the Purchaser or REG,
respectively, enforceable against the Purchaser or REG in
accordance with their respective terms, except as the
enforceability hereof may be subject to applicable bankruptcy,
insolvency, reorganization or other similar laws affecting
creditors’ rights generally and to general principles of
equity.
Section 3.3
Noncontravention. Neither the execution and
delivery by the Purchaser or REG of this Agreement and the
Transaction Documents, nor the consummation of the transactions
contemplated hereby or thereby, nor compliance with any of the
provisions hereof or thereof, will (a) violate any provision
of their respective Organizational Documents or any resolutions
adopted by their respective members or shareholders or board of
managers or board of directors, as applicable, (b) result in a
violation of any license, permit, order, writ, injunction, decree,
judgment, or ruling of any court or Governmental Authority, or any
law, rule, or regulation applicable to the Purchaser or REG,
(c) conflict with, result in a breach of, or constitute (or,
with due notice or lapse of time or both, would constitute) a
default under, or give rise to any right of termination,
acceleration or cancellation under, any indenture, agreement,
contract, license, arrangement, understanding, evidence of
indebtedness, note, lease or other instrument which constitutes an
material asset of the Purchaser or REG or to which the Purchaser or
REG or any of their material assets is bound, (d) result in
the creation or imposition of any lien (other than Permitted
Liens), charge, restriction, claim or Encumbrance of any nature
whatsoever upon the Purchaser or REG or the shares of REG Common
Stock or (e) require any consent or approval of, or notice to,
or filing or registration with, any Person, except for those
consents, approvals, notices, filings, or registrations that have
been obtained, given, or made, as the case may be, and that are
unconditional and in full force and effect.
Section 3.4
Capitalization; REG Common Stock.
REG is authorized to
issue two classes of shares designated respectively as
“Preferred Stock” and “Common Stock”.
The total number of shares of capital stock that REG is authorized
to issue is one hundred million (100,000,000). The total
number of shares of Preferred Stock REG has authority to issue is
thirty million (30,000,000). The total number of shares of
Common Stock REG has authority to issue is seventy million
(70,000,000). The Preferred Stock and Common Stock each have
a par value of $0.0001. REG has seven million (7,000,000)
shares of its Series A Preferred Stock authorized of which
6,578,947 are issued and outstanding and two million (2,000,000)
shares of its Series B Preferred Stock authorized of which
1,999,998 are issued and outstanding. REG has 13,334,874
shares of its Common Stock issued and outstanding. There are
issued and outstanding options to purchase 2,303,052 shares of REG
Common Stock pursuant to stock
14
option agreements issued
under the REG 2006 Stock Incentive Plan and issued and outstanding
warrants to purchase 633,533 shares of REG Common Stock. The
shares of REG Common Stock and Escrowed Stock to be issued to the
Company shall have the rights, restrictions, privileges and
preferences set forth in the Certificate of Incorporation of REG, a
true and correct copy of which Certificate of Incorporation
(including all amendments thereto) has been delivered to
Sellers. The REG Common Stock and the Escrowed Stock, when
issued and delivered to the Company or deposited into the Escrow
Fund, as applicable, in accordance with the terms of this Agreement
for the consideration expressed herein, will be duly and validly
issued, fully paid and non-assessable, free and clear of all
encumbrances except as provided in this Agreement and the
Stockholder Agreement and under applicable state and federal
securities laws. Except as contemplated in the Stockholder
Agreement or with respect to REG’s Series A and
Series B Preferred Stock, there are no contractual rights or
obligations of REG to repurchase, redeem or otherwise acquire any
shares of its capital stock, and REG is not a party or subject to
any agreement or understanding. Except as set forth
i
|